Today: 9 April 2026
Subscribe
Browse Category

NYSE:ABT 7 July 2025 - 19 November 2025

Abbott (ABT) Stock Slides on Mixed Q3 Results – Is a Rally Over?

Abbott Nears Takeover of Exact Sciences, Sending Cancer Test Maker’s Stock Soaring on November 19, 2025

Abbott Laboratories is in advanced talks to acquire Exact Sciences, sources told Bloomberg on Wednesday, in what would be Abbott’s largest deal since 2016. Exact Sciences shares surged up to 29% intraday, reaching a market value near $16 billion, while Abbott stock fell around 3%. No official comments have been made by either company.
19 November 2025
···
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 20.10.2025

Fed Chair Jerome Powell signaled the central bank may soon pause its balance-sheet runoff, hinting at an end to quantitative tightening. The move could ease monetary conditions and support stocks, though risks remain if earnings weaken. AbbVie and Abbott Laboratories continue to deliver steady dividend growth, appealing to long-term income investors. Walmart’s new OpenAI partnership and AI-driven features have lifted its shares despite sector headwinds.
20 October 2025
···
Abbott (ABT) Stock Slides on Mixed Q3 Results – Is a Rally Over?

Abbott (ABT) Stock Slides on Mixed Q3 Results – Is a Rally Over?

ABT shares closed at $128 on Oct. 15, down 3.5% for the day and about 2% for the week. Abbott reported Q3 revenue of $11.37 billion, up 6.9% year-over-year but slightly below estimates; adjusted EPS matched forecasts at $1.30. Medical Devices drove growth, while Diagnostics fell 6.6%. Investors sold off the stock after in-line results, with analysts maintaining a Hold rating and a $143.50 median price target.
15 October 2025
··
Global Wearable Health Tech News – June and July 2025

Global Wearable Health Tech News – June and July 2025

Biobeat’s cuffless vital-sign patch received FDA clearance and CE marking for remote hospital monitoring. PharmaSens and SiBionics unveiled the niia™ signature patch, combining a continuous glucose monitor and insulin pump, at ADA 2025. Fasikl’s Felix NeuroAI Wristband became the first FDA-cleared neuromodulation wearable for essential tremor. U.S. HHS Secretary RFK Jr. launched the MAHA initiative for nationwide wearable adoption.
7 July 2025
···
1 2 3

Stock Market Today

  • Bel Fuse, Enpro, Installed Building Products Stocks Surge as Crude Oil Prices Plunge
    April 9, 2026, 2:23 AM EDT. Shares of Bel Fuse, Enpro, and Installed Building Products soared following a sharp 17% drop in crude oil futures. The decline came after a two-week suspension of attacks on Iran was announced, easing fears of an energy crisis. The industrial sector, which is highly sensitive to energy costs and global trade, benefited from expectations of smoother supply chains and cheaper manufacturing inputs. Bel Fuse shares, known for volatility, rose amid recovery from recent declines tied to geopolitical tensions. Bel Fuse's stock is up 39% year-to-date, near its 52-week high, with a strong five-year growth record. Investors view the development as positive but not transformative. The reopening of the Strait of Hormuz is key to stabilizing raw material flows critical for industrial activity.

Latest article

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

US Stock Market Today: Live Updates 09.04.2026

9 April 2026
LIVEMarkets rolling coverageStarted: April 9, 2026, 12:00 AM EDTUpdated: April 9, 2026, 2:35 AM EDT Bel Fuse, Enpro, Installed Building Products Stocks Surge as Crude Oil Prices Plunge April 9, 2026, 2:23 AM EDT. Shares of Bel Fuse, Enpro, and Installed Building Products soared following a sharp 17% drop in crude oil futures. The decline came after a two-week suspension of attacks on Iran was announced, easing fears of an energy crisis. The industrial sector, which is highly sensitive to energy costs and global trade, benefited from expectations of smoother supply chains and cheaper manufacturing inputs. Bel Fuse shares, known
Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

Why IREN Stock Is Back in Focus as AI Ambitions Meet Funding Fears

8 April 2026
IREN shares rose 1.8% to $35.74 Wednesday as investors assessed its $6 billion share program and shift from bitcoin mining to AI cloud services. The company’s revenue fell to $184.7 million last quarter, with a net loss of $155.4 million. IREN recently announced a five-year, $9.7 billion AI cloud deal with Microsoft. Options trading volume hit 103,000 contracts Tuesday, with sentiment described as mixed.
Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

Amazon Stock Could Jump 50% as Wall Street Reconsiders Its $200 Billion AI Bet

8 April 2026
Amazon closed at $213.77 Tuesday, with BNP Paribas maintaining a $320 price target, citing strong AI demand despite Amazon’s planned $200 billion capex for 2026. The company’s February forecast of higher spending sent shares down 11.5% after hours, even as AWS revenue rose 24% to $35.6 billion in the December quarter. Alphabet and Microsoft are also ramping up AI infrastructure spending.
Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

Sensex Soars 2,946 Points, Nifty Near 24,000 After Iran Ceasefire and RBI Pause

8 April 2026
The Sensex surged 2,946 points to 77,562.90 on Wednesday, its best day in five years, as a U.S.-Iran ceasefire and steady RBI rates pushed Indian markets higher. Brent crude fell 14.4% to $93.49 a barrel, easing pressure on the rupee, which rose 0.5% to 92.58 per dollar. All 16 major sectors gained, led by financials and auto stocks. The RBI kept its repo rate at 5.25% and forecast slower growth ahead.
Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

Netflix Stock Draws Fresh Institutional Buying Ahead of Earnings After Goldman Upgrade

8 April 2026
Stock Yards Bank & Trust Co. increased its Netflix stake by 1,141.9% to 29,074 shares in Q4, while Ethos Capital Management disclosed a new 19,610-share position worth $1.84 million. The moves come ahead of Netflix’s April 16 earnings report and follow a Goldman Sachs upgrade to Buy with a $120 target. Insiders Reed Hastings and Greg Peters sold shares earlier this year under preset trading plans. Netflix last traded at $98.82.
Go toTop